| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/13/2007 | US7189706 C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them |
| 03/13/2007 | US7189696 Peptide antagonists of zonulin and methods for use of the same |
| 03/13/2007 | US7189562 Mononuclear phagocytes in therapeutic drug delivery |
| 03/13/2007 | US7189537 Comprises oncogenic nucleotide sequences for use in diagnosis, prevention and treatment of various cancers; gene therapy and antisense agents |
| 03/13/2007 | US7189535 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 03/13/2007 | US7189525 Human enzymes of the metalloprotease family |
| 03/13/2007 | US7189517 Goodpasture antigen binding protein |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | US7189383 Compounds with halogen for diagnosis with ethers or sulfides for cancer |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2274756C Methods and pharmaceutical compositions for inhibiting tumour cell growth |
| 03/13/2007 | CA2267224C Vitronectin receptor antagonists |
| 03/13/2007 | CA2264063C Cryptophycin compounds |
| 03/13/2007 | CA2240494C Therapeutic molecules generated by trans-splicing |
| 03/13/2007 | CA2222966C Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 03/13/2007 | CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 03/13/2007 | CA2112866C Novel derivatives of 2-cyano-3-hydroxy-propenamides, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 03/13/2007 | CA1341522C Novel granulocyte colony stimulating factor polypeptide derivatives |
| 03/08/2007 | WO2007028171A1 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
| 03/08/2007 | WO2007027834A1 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
| 03/08/2007 | WO2007027729A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 03/08/2007 | WO2007027714A2 Engineered anti-il-23 antibodies |
| 03/08/2007 | WO2007027594A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 03/08/2007 | WO2007027528A2 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 03/08/2007 | WO2007026960A1 Use of mocs3 gene for therapeutic or diagnostic purposes |
| 03/08/2007 | WO2007026869A1 Antitumor agent |
| 03/08/2007 | WO2007026725A2 Drug, drug gudance system, magnetic detection system, and drug design method |
| 03/08/2007 | WO2007026689A1 Antibody produced using ostrich and method for production thereof |
| 03/08/2007 | WO2007026533A1 Soluble tablet containing nanosilicon particles and process for production thereof |
| 03/08/2007 | WO2007026240A1 Sunscreen and cosmetic compositions for prophylaxis or treatment of skin cancers |
| 03/08/2007 | WO2007026203A1 A pharmaceutical composition comprising mahanine useful for the treatment of prostate cancer |
| 03/08/2007 | WO2007026201A1 A pharmaceutical composition useful for the treatment of prostate cancer |
| 03/08/2007 | WO2007026157A1 Atm inhibitor |
| 03/08/2007 | WO2007026146A1 Treatment using herpes simplex virus |
| 03/08/2007 | WO2007026027A1 Novel ansamycin derivatives |
| 03/08/2007 | WO2007025718A1 Oxadiazole compounds as urokinase inhibitors |
| 03/08/2007 | WO2007025534A1 Fredericamycin derivatives |
| 03/08/2007 | WO2007025388A2 Anti-apoptotic protein antibodies |
| 03/08/2007 | WO2007025365A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 03/08/2007 | WO2007011216A3 Bifunctional protein anchors |
| 03/08/2007 | WO2007011216A2 Bifunctional protein anchors |
| 03/08/2007 | WO2007009395A8 Schisandrin b preparation |
| 03/08/2007 | WO2007005668A3 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 03/08/2007 | WO2007004869A3 Treatment of tumors |
| 03/08/2007 | WO2006137009A3 Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents |
| 03/08/2007 | WO2006125539A3 Combination therapy comprising diaryl ureas for treating diseases |
| 03/08/2007 | WO2006110175A3 Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor |
| 03/08/2007 | WO2006108682A3 Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use as anti-fungal agents |
| 03/08/2007 | WO2006105021A3 Gitr binding molecules and uses therefor |
| 03/08/2007 | WO2006099445A3 Nanocells for diagnosis and treatment of diseases and disorders |
| 03/08/2007 | WO2006074451A3 Targeted chimeric molecules for cancer therapy |
| 03/08/2007 | WO2006071983A3 Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines |
| 03/08/2007 | WO2006038101A3 Novel cancer associated antibodies and antigens and their use in cancer diagnosis |
| 03/08/2007 | WO2005110486A3 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists |
| 03/08/2007 | WO2004026846A8 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy |
| 03/08/2007 | WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 03/08/2007 | WO2003020702A3 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 03/08/2007 | US20070055459 Structure-based approach to design of protein-processivity factor interactions |
| 03/08/2007 | US20070054956 6-(4-Methoxy-phenyl)-5-{4-[4-(4,4,5,5,5-pentafluoropentylsulfanyl/ pentafluoropentanesulfinyl)-butoxy]-phenoxy}-naphthalen-2-ol; anticarcinogenic agent; breast cancer, metastases to the bone or brain, radiation fibrosis and neutropenic sepsis |
| 03/08/2007 | US20070054923 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054922 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054920 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists |
| 03/08/2007 | US20070054899 Aromatase inhibitor compounds and uses thereof |
| 03/08/2007 | US20070054898 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054895 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer |
| 03/08/2007 | US20070054861 Therapeutic uses of SMR1 peptides |
| 03/08/2007 | US20070054364 Polypeptide variants |
| 03/08/2007 | US20070054363 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 03/08/2007 | US20070054328 Methods |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070054284 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 03/08/2007 | US20070053922 Epitope based vaccines directed towards HPV; side effect reduction; vaccination |
| 03/08/2007 | US20070053915 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
| 03/08/2007 | US20070053905 treating chondroma and chondrosarcoma by administering humanized anti-PTHrP(1-34) antibody which inhibits binding of parathyroid hormone related peptide to a receptor thereof |
| 03/08/2007 | US20070053902 Anti-alphabeta3 humanized monoclonal antibodies |
| 03/08/2007 | US20070053836 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/08/2007 | US20070053833 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 03/08/2007 | DE19958198B4 Mit dem IGF-1 Rezeptor wechselwirkende Proteine (IIPs) With the IGF-1 receptor interacting proteins (IIPs) |
| 03/08/2007 | DE102005041760A1 New fredericamycin A derivatives with carbon-bonded B-ring substituent, are well tolerated topoisomerase I and/or II inhibitors especially useful for treating cancers or tumors |
| 03/08/2007 | DE102005041616A1 Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und deren Verwendungen Melanoma-associated MHC class I-associated oligopeptides and their uses |
| 03/08/2007 | DE102005041613A1 Use of octahydro-indolo-quinoline compound in the preparation of pharmaceutical composition for the treatment and prophylaxis of gastrointestinal and endocardial disease and carcinoid syndrome |
| 03/08/2007 | CA2848021A1 Compostions and methods for preparation of poorly water soluble drugs with increased stability |
| 03/08/2007 | CA2845095A1 methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
| 03/08/2007 | CA2825762A1 Method for enhancing anti-neoplastic activity of an oncolytic virus using modified dendritic cells |
| 03/08/2007 | CA2625951A1 Anti-apoptotic protein antibodies |
| 03/08/2007 | CA2621377A1 Antitumor agent |
| 03/08/2007 | CA2621136A1 Immunological uses of immunodulatory compounds for vaccine and anti-infectious disease therapy |
| 03/08/2007 | CA2621127A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 03/08/2007 | CA2621083A1 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| 03/08/2007 | CA2620915A1 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
| 03/08/2007 | CA2620864A1 Raf inhibitor compounds and methods of use thereof |
| 03/08/2007 | CA2620802A1 Engineered anti-il-23 antibodies |
| 03/08/2007 | CA2620683A1 Oxadiazole compounds as urokinase inhibitors |
| 03/08/2007 | CA2620631A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 03/08/2007 | CA2620352A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 03/08/2007 | CA2620269A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| 03/08/2007 | CA2620023A1 Novel ansamycin derivatives |